Henry Schein Inc (STU:HS2)
€ 73.1 -0.18 (-0.25%) Market Cap: 9.10 Bil Enterprise Value: 11.81 Bil PE Ratio: 31.58 PB Ratio: 2.75 GF Score: 84/100

Henry Schein Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 07:25PM GMT
Release Date Price: €54.73 (-1.17%)
Steven James Valiquette;Steven Paladino
Barclays Bank PLC, Research Division - Research Analyst;Henry Schein, Inc.

All right. Great. Okay. Well, good afternoon, everyone. Welcome to the continuation of day 1 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays.

Our next session will be with Henry Schein. With us from the company, we have Stanley Bergman, the Chairman and CEO; Steve Paladino, the CFO; also, Carolynne Borders from Investor Relations. I always try to say the number of years that we've had the same C-suite of this company. I'm always off -- I always understate it by a few years. We're probably well past 25 at this point, but it could go something way beyond that. So I'm not going to try to guess that number anymore, but I suppose you guys probably know the whole management team pretty well.

This will be a fireside chat. But before we do that, I think I'm going to flip it over to Steve Paladino where he'll go through a couple of slides, and then we'll dive into some questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot